BIIB · Healthcare

BIOGEN INC.

Ranked earnings events from SEC filings, earnings calls, press releases and news. Full Picture: what to focus on this earnings window

News · 2026-08-07

• Acquisition / Partnership / DivestitureImportance 71 · Surprise 60
  Biogen completed its acquisition of RayThera, Inc. on August 6, 2026, expanding its immunology portfolio with multiple small-molecule assets. The transaction carries total consideration of up to $1 billion, comprising…
• Litigation and Legal RiskImportance 28 · Surprise 42
  Biogen reached a preliminary settlement agreement with investors in a class-action lawsuit concerning disclosures about clinical trial data for its Alzheimer’s drug Aduhelm. The plaintiffs alleged that Biogen…

News · 2026-08-06

• Acquisition / Partnership / DivestitureImportance 71 · Surprise 60
  Biogen completed its acquisition of RayThera, Inc. on August 6, 2026, expanding its immunology portfolio with multiple small-molecule assets. The transaction carries total consideration of up to $1 billion, comprising…
• Product / Drug Pipeline ProgressImportance 37 · Surprise 42
  Denali Therapeutics discontinued the Parkinson’s disease program BIIB122/DNL151 after its Phase 2b study failed to meet endpoints. BIIB122/DNL151 was being developed in collaboration with Biogen, making the…